Applied Genetic (AGTC)

Name: Applied Genetic (AGTC) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Applied Genetic (AGTC)

Stock Card

$0.39

$0.00 (0.00%)

As on 09-Dec-2022 09:30EDT

Market cap

$27 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

P/B Ratio

1.5

Div. Yield

0 %

Applied Genetic (AGTC) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 0.39 High: 0.39

52 Week Range

Low: -- High: --

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$-70 Mln
ROE

-1.6 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

-0.2
Debt to Equity

0.4
Book Value

$--
EPS

$-1.5
Face value

--
Shares outstanding

67,632,200

10 Years Aggregate

CFO

$-208.72 Mln

EBITDA

$-228.04 Mln

Net Profit

$-242.16 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Applied Genetic (AGTC)	-79.3	-1.6	-4.2	-82.5	-48.4	-36.5	--
BSE Sensex^*	-9.1	-1.2	2.9	-3.6	5.7	6.2	10.5
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 09-Dec-2022 | *As on 31-Aug-2026 | #As on 26-Oct-2023

Company	2021	2020	2019	2018	2017	2016	2015
Applied Genetic (AGTC)	-53.5	-9.5	81.5	-30.7	-61.5	-54.2	-2.9
S&P Small-Cap 600	25.3	9.6	20.9	-9.7	11.7	24.7	-3.4
BSE Sensex	22.0	15.8	14.4	5.9	27.9	1.9	-5.0

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Applied Genetic (AGTC)	0.4	26.6	0.3	-70.2	-21,080.9	-217.2	--	1.5
AkouosÂ Inc (AKUS)	13.3	491.0	0.0	-92.6	--	-47.5	--	2.7

Shareholding Pattern

View Details

About Applied Genetic (AGTC)

Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology... development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase 1/2 clinical trials; and achromatopsia that is in Phase 1/2 clinical trials. It is also developing an optogenetic product candidate to treat advanced retinal disease. In addition, the company has initiated one preclinical program in otology; preclinical program in dry age-related macular degeneration; and two preclinical programs in targeting central nervous system disorders, including frontotemporal dementia and amyotrophic lateral sclerosis. It has collaboration agreements with University of Florida; Bionic Sight, Inc.; and Otonomy, Inc. The company was incorporated in 1999 and is headquartered in Alachua, Florida. Read more

Pres, CEO & Director

Ms. Susan B. Washer
Pres, CEO & Director

Ms. Susan B. Washer
Headquarters

Alachua, FL
Website

https://agtc.com

FAQs for Applied Genetic (AGTC)

What is the current share price of Applied Genetic (AGTC) Today?

The share price of Applied Genetic (AGTC) is $0.39 (NASDAQ) as of 09-Dec-2022 09:30 EDT. Applied Genetic (AGTC) has given a return of -48.43% in the last 3 years.

What is the current PB & PE ratio of Applied Genetic (AGTC)?

Since, TTM earnings of Applied Genetic (AGTC) is negative, P/E ratio is not available.
The P/B ratio of Applied Genetic (AGTC) is 1.51 times as on 09-Dec-2022, a 70 discount to its peers’ median range of 4.96 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2022	-0.50	1.18
2021	-2.23	1.50
2020	-2.54	1.64
2019	-34.01	0.87
2018	-3.13	0.67

What is the 52 Week High and Low of Applied Genetic (AGTC)?

The 52-week high and low of Applied Genetic (AGTC) are Rs -- and Rs -- as of 31-Aug-2026.

What is the market cap of Applied Genetic (AGTC)?

Applied Genetic (AGTC) has a market capitalisation of $ 27 Mln as on 09-Dec-2022. As per SEBI classification, it is a Small Cap company.

Should I invest in Applied Genetic (AGTC)?

Before investing in Applied Genetic (AGTC), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.